Safety and efficacy of routine upstream initiation vs deferred selective use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes: a meta-analysis | Zendy

AI Assistant Blog Pricing

Safety and efficacy of routine upstream initiation vs deferred selective use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes: a meta-analysis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.